Methylin and Simvastatin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Methylin (methylphenidate hydrochloride) and Simvastatin (simvastatin). Common drug interactions include osteoarthritis among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Methylin and Simvastatin. It is created by eHealthMe based on reports of 56 people who take the same drugs from the FDA, and is updated regularly.

What is Methylin?

Methylin has active ingredients of methylphenidate hydrochloride. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 1,116 Methylin users. Check the latest studies of Methylin.

What is Simvastatin?

Simvastatin has active ingredients of simvastatin. It is often used in high blood cholesterol. eHealthMe is studying from 256,970 Simvastatin users. Check the latest studies of Simvastatin.



On Aug, 07, 2026

56 people who take Methylin and Simvastatin together, and have interactions are studied.

Methylin and Simvastatin drug interactions.

What are the common drug interactions of Methylin and Simvastatin, by gender? *:

female:

  1. Osteoarthritis (a joint disease caused by cartilage loss in a joint)
  2. Osteomyelitis (infection of bone)
  3. Osteonecrosis of jaw (death of bone of jaw)
  4. Radiation injury (injuries are caused by radiation)
  5. Sinus disorder (disease of sinus)
  6. Sinusitis fungal (fungal infection of sinus)
  7. Cerebral ischaemia (insufficient blood flow to the brain to meet metabolic demand)
  8. Joint dislocation (a joint position is changed from normal position)
  9. Scoliosis (a medical condition in which a person's spine is curved from side to side)
  10. Cerumen impaction

male:

  1. Chronic kidney disease
  2. Renal injury (kidney injury)
  3. Anxiety
  4. Crying
  5. Decreased appetite
  6. Dizziness
  7. Drug ineffective
  8. Dyspnoea (difficult or laboured respiration)
  9. Glaucoma (increased fluid pressure in the eye with vision loss)
  10. Hostility

What are the common drug interactions of Methylin and Simvastatin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  4. Loss of consciousness

40-49:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)

50-59:

  1. Depressed mood
  2. Diarrhoea
  3. Disturbance in attention
  4. Dysphagia (a condition in which swallowing is difficult or painful)
  5. Fear
  6. Hypokalaemia (low potassium)
  7. Joint dislocation (a joint position is changed from normal position)
  8. Sleep disorder
  9. Small intestinal obstruction (blockage in small intestine)
  10. Stress

60+:

  1. Depression
  2. Fall
  3. Arteriosclerosis (thickening and hardening of arteries)
  4. Asthenia (weakness)
  5. Back pain
  6. Brain neoplasm (tumour of brain)
  7. Breast cancer metastatic
  8. Carotid bruit (sound heard over the carotid artery area during auscultation)
  9. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  10. Chronic sinusitis (long lasting inflammation of the paranasal sinuses)

What are the existing conditions these people have? *

  1. Hypercalcaemia Of Malignancy (elevated calcium (ca+) level in the blood with cancer): 16 people, 28.57%
  2. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 14 people, 25.00%
  3. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 8.93%
  4. Drowsiness: 5 people, 8.93%
  5. Pain: 4 people, 7.14%
  6. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 4 people, 7.14%
  7. High Blood Pressure: 4 people, 7.14%
  8. Depression: 4 people, 7.14%
  9. Insomnia (sleeplessness): 3 people, 5.36%
  10. Gout (uric acid crystals building up in the body): 3 people, 5.36%

* Approximation only. Some reports may have incomplete information.

Do you take Methylin and Simvastatin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Methylin and Simvastatin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Methylin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Simvastatin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Methylin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Simvastatin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on methylphenidate hydrochloride and simvastatin (the active ingredients of Methylin and Simvastatin, respectively), and Methylin and Simvastatin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: